Role of Estrogen in the Menstrual Cycle

Estrogen — measured in the blood as estradiol, and spelled oestrogen or oestradiol on some lab reports — is what turns a growing follicle into a cycle. Granulosa cells in the developing follicles make it under FSH stimulation, its rise thickens the uterine lining, and once it reaches and holds a high enough level it switches the pituitary from suppression to a burst of LH, which triggers ovulation. After ovulation the corpus luteum makes progesterone alongside a second, smaller estradiol rise.

Four things happen in sequence, and the order matters more than any single level:

• FSH stimulates granulosa cells, which proliferate and produce estradiol (StatPearls, Proliferative and Follicular Phases of the Menstrual Cycle).
• Rising estradiol thickens the endometrium, which begins the proliferative phase at about 0.5 to 5 mm (same source).
• Peak estradiol flips pituitary feedback from negative to positive, producing a roughly ten-fold rise in LH (StatPearls, Physiology, Menstrual Cycle, 2024).
• Ovulation follows about 36 to 44 hours after the surge begins, and the luteal phase then runs about 14 days (same source).

The most precise description of the mid-cycle switch comes from a 1983 study that sampled five women every 2 hours for 5 consecutive days around ovulation (Hoff, Quigley and Yen, Journal of Clinical Endocrinology and Metabolism 1983;57(4):792-6). In the 50 hours before the surge started, estradiol, progesterone and LH all climbed at a similar rate, with doubling times of 57 to 61 hours. Then the surge began abruptly — LH doubled within 2 hours — at the point estradiol reached its peak.

The surge itself lasted a mean of 48 hours in that study: a fast ascending limb of about 14 hours, a plateau of about 14 hours, and a slower 20-hour decline. Estradiol falls sharply as the surge climbs.

This is why timing questions have crisp answers and level questions do not. The interval from surge to ovulation is reasonably tight. The level that triggers the surge is not a single number you can look up on a report — it is a peak that has to be sustained, and the study measured rates of change rather than a threshold.

The 28-day cycle with ovulation on day 14 is a teaching diagram, not a description of most cycles. In an analysis of 612,613 ovulatory cycles from 124,648 users, mean cycle length was 29.3 days and only 13% of cycles were exactly 28 days long (Bull et al, npj Digital Medicine 2019).

More useful than the average is where the variation sits. In the same dataset, mean follicular phase length was 16.9 days while mean luteal phase length was 12.4 days — and the variation in total cycle length was attributed mainly to the timing of ovulation, meaning the follicular phase. A prospective study of 141 regularly cycling women producing 1,060 cycles found the same pattern: mean length 28.9 days, 95% of cycles between 22 and 36 days, and the follicular phase contributing most of the variability (Fehring, Schneider and Raviele, Journal of Obstetric, Gynecologic and Neonatal Nursing 2006;35(3):376-84).

That study also found that only 25% of participants had all their fertile days between days 10 and 17. So a longer or shorter cycle usually reflects how long estradiol took to bring a follicle to the point of triggering the surge, not a defect in the second half of the cycle.

The proliferative phase is named for what estradiol does to the endometrium. It starts thin — about 0.5 to 5 mm — and thickens as estradiol rises, before progesterone converts it to a secretory lining after ovulation (StatPearls, Proliferative and Follicular Phases of the Menstrual Cycle).

Because that is visible on a scan, endometrial thickness gets treated as a verdict. The largest synthesis of it does not support that reading. A systematic review and meta-analysis of 22 studies found a thin endometrium of 7 mm or less in only 2.4% of reported cases, 260 of 10,724, and clinical pregnancy in those cases was 23.3% against 48.1% with a thicker lining, odds ratio 0.42 (95% CI 0.27 to 0.67). The authors concluded that thickness has “virtually absent” discriminatory capacity for predicting pregnancy, and that using it to cancel a cycle or freeze all embryos is not justified (Kasius et al, Human Reproduction Update 2014;20(4):530-41).

In other words: the lining responds to estradiol, a 7 mm cut-off is associated with lower pregnancy chances, and it is both uncommon and a poor predictor in any individual cycle. More on that in Understanding Thin Endometrium.

Indian laboratories report estradiol either in pg/mL or in pmol/L. The two are the same measurement: estradiol has a molecular weight of 272.4 g/mol (PubChem CID 5757), so 1 pg/mL is about 3.67 pmol/L. A result that looks alarmingly different from one you read elsewhere is often just the other unit.

The bigger issue is what the number is being asked to do. ASRM's 2020 committee opinion on ovarian reserve testing states plainly that basal estradiol alone should not be used to screen for diminished ovarian reserve. Its value is as a check on FSH: an early rise in estradiol is a characteristic of reproductive aging and can pull an otherwise elevated FSH back into the normal range, producing a falsely reassuring result. Where FSH is normal but basal estradiol is elevated above roughly 60 to 80 pg/mL, that combination may itself point to diminished ovarian reserve.

Two practical consequences for anyone handed a hormone panel:

• The cycle day the blood was drawn changes the interpretation entirely — a follicular-phase estradiol and a mid-luteal one are not comparable, so the day should be on the report.
• Estradiol is read with FSH, not instead of it. On its own it neither confirms nor excludes anything about ovarian reserve.
• Estradiol does not confirm that ovulation happened. A luteal progesterone above 3 ng/mL is what indicates ovulation occurred (StatPearls, Physiology, Progesterone).

How the three hormones are read together is covered in Role of FSH, LH, and Estradiol in Fertility, and what a scan-based follicular study adds in Follicular Study: What It Reveals.

Estradiol sets up the fertile window; it does not mark it. In a study of 221 women trying to conceive, with 625 cycles in which the day of ovulation could be estimated from urinary estrogen and progesterone metabolites, conception occurred only when intercourse took place in a six-day period ending on the day of ovulation. The probability of conception ranged from 0.10 for intercourse five days before ovulation to 0.33 on the day of ovulation itself (Wilcox, Weinberg and Baird, New England Journal of Medicine 1995;333:1517-21).

Home ovulation kits detect the LH surge rather than estradiol, which is a reasonable proxy but an imperfect one. In 107 normally fertile women followed over 283 cycles with daily urine sampling and serial ovarian ultrasound, individual LH surges were “extremely variable in configuration, amplitude, and duration”, and the authors advised comparing an LH profile against the range seen in fertile cycles rather than against a textbook mean (Direito et al, Fertility and Sterility 2013;99(1):279-285).

Several claims attach themselves to this topic that the sources cited here do not support.

• “Estrogen dominance” as a diagnosis. None of the guidance retrieved here defines it, sets a threshold for it, or establishes it as a cause of endometriosis or PCOS. A symptom pattern is not a hormone result.
• That diet corrects estrogen levels. In a meta-analysis of 47 studies, soy and isoflavones did not change estradiol, estrone or SHBG concentrations in premenopausal women; FSH and LH fell by about 20% pooled, and cycle length increased by 1.05 days (95% CI 0.13 to 1.97, 10 studies) — changes the authors described as modest and of undetermined clinical significance (Hooper et al, Human Reproduction Update 2009;15(4):423-40). Flaxseed and seed-cycling protocols have no equivalent evidence retrieved here at all.
• That a single estradiol value predicts fertility. ASRM 2020 states basal estradiol alone should not be used as a screen.
• That endometrial thickness decides an outcome. The 7 mm cut-off is associated with lower clinical pregnancy, but had virtually absent discriminatory power in the Kasius meta-analysis.
• That estrogen levels explain cycle-related mood changes. No source retrieved for this article establishes that link, and it is asserted far more often than it is measured.

What is established is narrower and more useful: estradiol drives follicular growth and endometrial proliferation, its peak triggers the LH surge, and the surge-to-ovulation interval is about 36 to 44 hours.

Cycle length varies normally — 95% of cycles fell between 22 and 36 days in the Fehring cohort — so a cycle that is not 28 days is not in itself a finding. What is worth investigating is a change from someone's own pattern, cycles that stop, or cycles far outside that range.

The sequence that usually follows is testing rather than treatment. Ovulation is confirmed with a luteal progesterone, thyroid function and prolactin are checked because both can disturb cycles, and FSH is read with estradiol rather than alone. Where cycles are absent or very long, the question is which diagnosis explains it — and the answer is frequently something treated with medication or weight and metabolic management rather than with IVF.

Related: Irregular Periods and Fertility, Understanding Anovulation, and Low Estrogen and Fertility: What It Means and When It Matters.